MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading Into 2026NEWARK, DE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ...
Morningstar

Hohenstein Medical Earns GLP Certification for Medical Device Testing

Good Laboratory Practice certification expands company's ability to support medical device manufacturers in meeting the complex demands of international regulatory frameworks "Our customers are ...